Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
6.00
+0.15 (2.56%)
At close: Apr 28, 2026, 4:00 PM EDT
5.99
-0.01 (-0.17%)
After-hours: Apr 28, 2026, 7:53 PM EDT
Teladoc Health Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Teladoc Health stock have an average target of 7.56, with a low estimate of 5.00 and a high estimate of 11. The average target predicts an increase of 26.00% from the current stock price of 6.00.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Teladoc Health stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 2 | 2 | 2 | 1 | 2 | 2 |
| Hold | 10 | 10 | 10 | 12 | 13 | 13 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 15 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $5 → $6 | Hold | Maintains | $5 → $6 | n/a | Apr 8, 2026 |
| Barclays | Barclays | Hold Maintains $8.5 → $7 | Hold | Maintains | $8.5 → $7 | +16.67% | Mar 26, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $9 → $7 | Hold | Maintains | $9 → $7 | +16.67% | Mar 13, 2026 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $11 | Hold → Strong Buy | Upgrades | $11 | +83.33% | Mar 10, 2026 |
| Citigroup | Citigroup | Hold Maintains $9 → $6 | Hold | Maintains | $9 → $6 | n/a | Mar 3, 2026 |
Financial Forecast
Revenue This Year
2.56B
from 2.53B
Increased by 1.19%
Revenue Next Year
2.59B
from 2.56B
Increased by 1.25%
EPS This Year
-0.87
from -1.14
EPS Next Year
-0.74
from -0.87
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 2.7B | 2.7B | ||||
| Avg | 2.6B | 2.6B | ||||
| Low | 2.4B | 2.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 5.7% | 7.3% | ||||
| Avg | 1.2% | 1.3% | ||||
| Low | -4.1% | -5.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.45 | -0.43 | |||
| Avg | -0.87 | -0.74 | |||
| Low | -1.06 | -1.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.